PALO ALTO, Calif. – September 10, 2026 – Vivo Capital (“Vivo” or the “Firm”), a leading global healthcare investment firm, today announced the appointment of Mr. Neetesh Kumar as Managing Partner. Mr. Kumar will co-lead…
As Vivo Capital celebrates its 30th anniversary, we are launching a new philanthropic initiative that expands our commitment to advancing healthcare innovation globally and creating positive impact beyond investing.
PARIS & PALO ALTO, Calif.–(BUSINESS WIRE)–LBO France, a multi-specialist investment platform and pioneer in private equity, announced today the signing of a definitive agreement with Vivo Capital, a leading global investment firm focused exclusively on…
Suzhou, China, and Gembloux, Belgium – May 19, 2026 – Full-Life Technologies (“Full-Life”, the “Company”), a fully-integrated global radiotherapeutics company, today announced the completion of a US$150 million financing package, comprised of approximately US$109 million…
INDIANAPOLIS and NEW YORK and CAMBRIDGE, Mass., April 27, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Ajax Therapeutics, Inc. (“Ajax”), a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative…
SHANGHAI, China, April 10, 2026 – Oricell Therapeutics Holdings Limited (“Oricell”), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the closing of a pre-IPO financing round in excess of $110 million. The…
Dear Friends of Vivo, As we approach the 30th anniversary of Vivo’s founding, we have been reflecting on the remarkable journey that brought us here.
SAN DIEGO and REDWOOD CITY, Calif., April 6, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Soleno Therapeutics, Inc. (Nasdaq: SLNO) today announced that Neurocrine has entered into a definitive agreement to acquire Soleno…
RAHWAY, N.J. and FOSTER CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-stage oncology…
GALWAY, Ireland, March 10, 2026 /PRNewswire/ — Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition is valued at…